Homepage
amfAR, The Foundation for AIDS Research, is dedicated to ending the global AIDS epidemic through innovative research.
Shaping the Future of HIV Research
amfAR interviewed Gladstone Institutes’ Dr. Melanie Ott about her work on HIV, hepatitis C, and other viruses, and the promise of new technologies.
Can AI Help Piece Together the Puzzle of Cancer—and HIV?
New technology that more precisely analyzes patients’ biological data could deliver more effective, personalized treatment for people living with HIV.
How NIH Funding Fuels Innovation and Economic Growth
Continued investment in the NIH is essential to fighting current and emerging health threats and to ensuring the U.S. remains a global leader in medical innovation.
Explore more on Research, Policy and Advocacy, and TREAT Asia
Research Grants
amfAR utilizes formal requests for proposals to solicit grant applications for both targeted and general HIV/AIDS research. Proposals are then peer reviewed by the Scientific Advisory Committee on the basis of their relevance, scientific merit, and promise. To date, amfAR has awarded more than 3,800 grants to research teams worldwide.
Research Grants Awarded
Request for Proposals
Register by March 19, 2025, 3 PM EDT
Letter of Intent due March 27, 2025, 3 PM EDT
amfAR Announces Chief Executive Officer Succession Plan
Kevin Robert Frost to Retire at End of 2025;
Kyle Clifford to be Elevated to CEO
Donate to amfAR: Fuel Lifesaving Research
Make your contribution today and join the fight to #CureAIDS. Your support contributes to the advancement of amfAR’s cutting-edge HIV/AIDS research.
Show the world that a cure isn’t just possible—it’s within reach.
New Edition of amfAR Magazine Out Now
This issue features an interview with UNAIDS Executive Director Winnie Byanyima and coverage of the most recent studies of the drug lenacapavir for PrEP and the latest probable case of an HIV cure. Plus updates on our research, public policy, and TREAT Asia programs, and much more.
Leading the Way to a Cure
amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has raised nearly $900 million in support of its programs and has awarded more than 3,800 grants to research teams worldwide.